• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

BTB Therapeutics

Monday, June 03, 2024
CP
Pain Management
We are a clinical stage drug development company located in Kyoto, Japan. Our most advanced program is a non-opioid analgesic agent, ENDOPIN currently in phase 2a study.
BTB Therapeutics
Company Website: https://btb-newdrug.co.jp/en/index.html
Lead Product in Development: ENDOPIN, non-opioid analgesic
Number Of Unlicensed Products (For Which You Are Seeking Partners): 3

Company HQ City

Kyoto

Company HQ State

Kyoto

Company HQ Country

Japan

CEO/Top Company Official

Tsuyoshi Ogiku, PhD, CEO

Development Phase of Primary Product

Phase II
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS